Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
13 angezeigte Treffer · Seite 1, keine Gesamtzahl für „oritavancin“
Suchtreffer
Begriffe & Kennungen
Tenkasi (previously Orbactiv) · 4.3 · Use of intravenous unfractionated heparin sodium is contraindicated for 120 hours (5 days) after oritavancin a
Eintrag öffnenTenkasi (previously Orbactiv) · 4.3 · Use of intravenous unfractionated heparin sodium is contraindicated for 120 hours (5 days) after oritavancin a
Eintrag öffnenTenkasi (previously Orbactiv) · 4.5 · Caution should be used when administering oritavancin concomitantly with medicinal products with a narrow ther
Eintrag öffnenTenkasi (previously Orbactiv) · 4.5 · Caution should be used when administering oritavancin concomitantly with medicinal products with a narrow ther
Eintrag öffnenTenkasi (previously Orbactiv) · 4.5 · Oritavancin binds to and prevents the action of the phospholipid reagents which activate coagulation in common
Eintrag öffnenTenkasi (previously Orbactiv) · 4.5 · Oritavancin binds to and prevents the action of the phospholipid reagents which activate coagulation in common
Eintrag öffnenTenkasi (previously Orbactiv) · 4.5 · Table 1: Coagulation tests affected by oritavancin Assay Duration of interference
Eintrag öffnenTenkasi (previously Orbactiv) · 4.5 · Table 2: Coagulation tests affected by oritavancin Assay Duration of interference
Eintrag öffnenTenkasi (previously Orbactiv) · 4.8 · Adverse reactions for oritavancin from the pooled Phase 3 ABSSSI clinical trials with single dose oritavancin
Eintrag öffnenTenkasi (previously Orbactiv) · 4.8 · Adverse reactions for oritavancin from the pooled Phase 3 ABSSSI clinical trials with single-dose oritavancin
Eintrag öffnenoritavancin
Eintrag öffnenoritavancin (diphosphate)
Eintrag öffnenoritavancin diphosphate
Eintrag öffnen